Sun Pharma to acquire Checkpoint Therapeutics Inc for up to USD 355 million, expanding its oncology portfolio. The deal ...

For the nine-month period ending September 2024, Checkpoint reported $0.04 million in revenue and a net loss of $27.3 million.

Sun Pharmaceutical Industries said that it has entered into an agreement for the acquisition of all the outstanding shares of Checkpoint Therapeutics, Inc., an immunotherapy and targeted oncology ...

Sun Pharma acquires Checkpoint Therapeutics for $355 million, expanding its oncology portfolio with innovative treatments.

Ayushman Bharat PM-JAY is a health assurance scheme that aims to provide a health cover of Rs 5 lakhs per family per year for ...

The National Pharmacy Association (NPA) said the Government must urgently grant much greater flexibility for pharmacists ...

Enhanced tariffs on pharma imports in the US can severely impact Indian drug manufacturers as it would lead to higher ...

India's Sun Pharmaceutical Industries said on Monday it will acquire Checkpoint Therapeutics, a U.S.-based immunotherapy and ...

The deal is in line with Sun Pharma's active push in recent years to expand its oncology and immunotherapy portfolio through ...

Frustration is mounting as angry patients leave high street pharmacies empty-handed every day because of drug shortages and ...

The upfront cash payment of $4.10 per share of common stock represents a premium of around 66% to Checkpoint’s closing share ...